Clinical trials

  • EpisodicStatinMig. A multicentre, triple blind, placebo controlled, parallel group study of atorvastatin in episodic migraine. EudraCT Number 2022-502176-23-01. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim, Norway
  • Chronic StatinMig. A multicentre, triple blind, placebo controlled, parallel group study of atorvastatin in chronic migraine. EudraCT Number 2022-502177-42-02. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim, Norway
  • Nurse intervention Trial. Follow-up from headache nurse: An open randomized. REK #2023/554940. Role: Local PI. Sponsor institution: St. Olav’s Hospital, Trondheim, Norway
  • Interventional, randomized, double-blind, parallel-group, placebo-controlled study of add-on eptinezumab treatment to brief educational intervention for the preventive treatment of migraine in patients with dual diagnosis of migraine and medication overuse headache (RESOLUTION). EudraCT Number 2021-003049-40. Role: Local PI. Sponsor institution: H. Lundbeck A/S
  • MiBlock Study - Botulinum toxin type A blockade of the sphenopalatine ganglion in treatment-refractory chronic migraine: A randomized, placebo-controlled, triple-blind (blinded statistician), multicentre, parallel group proof-of-concept, phase 3 study. EudraCT Number 2018-004053-24. Role: Sub-PI. Sponsor institution: St. Olav’s Hospital and NTNU, Trondheim
 
Scroll to top